Future studies focused on dissecting the molecular interactions and regulatory functions of PKP2 in controlling cell–cell junction component expression and determining whether the role of PKP2 is solely structural or extends to the control of protein expression will provide deeper understanding of the complex role of PKP2 in the pathogenesis of ARVC. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.